Bill Maughan
Stock Analyst at Clear Street
(0.91)
# 3,987
Out of 5,150 analysts
22
Total ratings
42.86%
Success rate
-13.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bill Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Maintains: Buy | $21 → $28 | $10.76 | +160.22% | 1 | Mar 3, 2026 | |
| KRRO Korro Bio | Upgrades: Buy | $10 → $18 | $10.75 | +67.44% | 2 | Feb 19, 2026 | |
| CRBU Caribou Biosciences | Initiates: Buy | $13 | $1.76 | +638.64% | 1 | Feb 2, 2026 | |
| CLLS Cellectis | Initiates: Buy | $9 | $3.66 | +145.90% | 1 | Dec 23, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $22 → $47 | $13.44 | +249.70% | 2 | Dec 9, 2025 | |
| ANNX Annexon | Initiates: Buy | $17 | $5.43 | +213.08% | 1 | Dec 2, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | $100 | $55.45 | +80.34% | 1 | Sep 17, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $190 | $263.80 | -27.98% | 1 | Jul 1, 2025 | |
| CRSP CRISPR Therapeutics AG | Downgrades: Hold | $45 | $58.06 | -22.49% | 1 | Jun 27, 2025 | |
| NKTX Nkarta | Maintains: Buy | $16 → $15 | $2.57 | +483.66% | 2 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $9 | $1.37 | +556.93% | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $63 → $67 | $32.36 | +107.05% | 3 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $91 → $106 | $49.83 | +112.72% | 3 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $2.28 | +952.63% | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $5.50 | +990.91% | 1 | Feb 21, 2024 |
Ocular Therapeutix
Mar 3, 2026
Maintains: Buy
Price Target: $21 → $28
Current: $10.76
Upside: +160.22%
Korro Bio
Feb 19, 2026
Upgrades: Buy
Price Target: $10 → $18
Current: $10.75
Upside: +67.44%
Caribou Biosciences
Feb 2, 2026
Initiates: Buy
Price Target: $13
Current: $1.76
Upside: +638.64%
Cellectis
Dec 23, 2025
Initiates: Buy
Price Target: $9
Current: $3.66
Upside: +145.90%
Wave Life Sciences
Dec 9, 2025
Maintains: Buy
Price Target: $22 → $47
Current: $13.44
Upside: +249.70%
Annexon
Dec 2, 2025
Initiates: Buy
Price Target: $17
Current: $5.43
Upside: +213.08%
Dianthus Therapeutics
Sep 17, 2025
Initiates: Buy
Price Target: $100
Current: $55.45
Upside: +80.34%
Krystal Biotech
Jul 1, 2025
Initiates: Buy
Price Target: $190
Current: $263.80
Upside: -27.98%
CRISPR Therapeutics AG
Jun 27, 2025
Downgrades: Hold
Price Target: $45
Current: $58.06
Upside: -22.49%
Nkarta
May 10, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.57
Upside: +483.66%
May 10, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $1.37
Upside: +556.93%
May 9, 2024
Maintains: Hold
Price Target: $63 → $67
Current: $32.36
Upside: +107.05%
May 3, 2024
Maintains: Hold
Price Target: $91 → $106
Current: $49.83
Upside: +112.72%
Mar 15, 2024
Maintains: Buy
Price Target: $22 → $24
Current: $2.28
Upside: +952.63%
Feb 21, 2024
Reiterates: Buy
Price Target: $60
Current: $5.50
Upside: +990.91%